The Biotech Growth Trust PLC
BIOG.L · LSE
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | £256 | £238 | £337 | £336 |
| - Cash | £0 | £8 | £4 | £2 |
| + Debt | £28 | £0 | £39 | £47 |
| Enterprise Value | £284 | £230 | £372 | £381 |
| Revenue | £71 | -£86 | £10 | £91 |
| % Growth | 182.4% | -931.3% | -88.6% | – |
| Gross Profit | £0 | £0 | £10 | £88 |
| % Margin | 0% | -0% | 100% | 96.4% |
| EBITDA | £70 | -£88 | £8 | £0 |
| % Margin | 97.9% | 101.9% | 80.4% | 0% |
| Net Income | £69 | -£91 | £8 | £88 |
| % Margin | 97.5% | 105.1% | 78.1% | 97.3% |
| EPS Diluted | 2.73 | -2.87 | 0.25 | 2.44 |
| % Growth | 195.1% | -1,248% | -89.8% | – |
| Operating Cash Flow | -£3 | -£3 | -£3 | -£2 |
| Capital Expenditures | £0 | £0 | £0 | £0 |
| Free Cash Flow | -£3 | -£3 | -£3 | -£2 |